1. Belovičová M, Popovičová M, Vansáč P. The issue of the occurrence of diseases of civilization in social reintegration facilities. Bardejov: SSPO; 2021.
2.
Wróblewska I, Zborowska I, Dąbek A, et al. Health status, health behaviors, and the ability to perform everyday activities in Poles aged ≥ 65 years staying in their home environment. Clin Interv Aging 2018; 13: 355–363, doi: 10.2147/CIA.S152456.
3.
Pobrotyn P, Mazur G, Kałużna-Oleksy M, et al. The Level of Self-Care among Patients with Chronic Heart Failure. Healthcare 2021; 9(9): 1179, doi: 10.3390/healthcare9091179.
4.
Pobrotyn P, Pasieczna A, Diakowska D, et al. Evaluation of Frailty Syndrome and Adherence to Recommendations in Elderly Patients with Hypertension. J Clin Med 2021; 10(17): 3771, doi: 10.3390/jcm10173771.
5.
Wróblewska I, Talarska D, Wróblewska Z, et al. Pain and symptoms of depression: international comparative study on selected factors affecting the quality of life of elderly people residing in institutions in Europe. BMC Geriatr 2019; 19: 147, doi: 10.1186/s12877-019-1164-5.
6.
Susło R, Trnka J, Siewiera J, et al. Hypoxia-Related Brain Dysfunction in Forensic Medicine. Adv Exp Med Biol 2015; 837: 49–56, doi: 10.1007/5584_2014_84.
7.
Paciej P, Ciabiada B, Maniecka-Bryła I. Premature mortality due to alcohol-related diseases of the liver in Poland according to voivodships. Fam Med Prim Care Rev 2017; 19(3): 251–255, doi: 10.5114/fmpcr.2017.69287.
8.
Cholongitas E, Pavlopoulou I, Papatheodoridi M, et al. Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis. Ann Gastroenterol 2021; 34(3): 404–414, doi: 10.20524/aog.2021.0604.
9.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73–84.
10.
Sayiner M, Koenig A, Henry L, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis 2016; 20: 205–214.
11.
Leite NC, Villea-Nougueria CA, Cardosso CRL, et al. Non-alcoholic fatty liver disease and diabetes. From pathophysiological interplay to diagnosis and treatment. WJG 2014; 14: 20(26): 8377–8392, doi: 10.3748/wjg.v20.i26.8377.
12.
Dražilová S. Non-alcoholic fatty liver disease. In: Dražilová S, Gombošová L, Janíčko M, et al, eds. Selected chapters from hepatology and gastroenterology. Košice: UPJŠ LF; 2020: 249–265 (e-publication).
13.
Pobrotyn P, Susło R, Witczak I, et al. An analysis of the costs of treating aged patients in a large clinical hospital in Poland under the pressure of recent demographic trends. Arch Med Sci 2020; 16(3): 666–671, doi: 10.5114/aoms.2018.81132.
14.
Furtak-Pobrotyn J, Pobrotyn P, Rypicz Ł, et al. Forced prolonged hospital stays as a manifestation of the dysfunction of the Polish long-term care system. Fam Med Prim Care Rev 2018; 20: 218–221, doi: 10.5114/fmpcr.2018.78254.
15.
Trnka J, Drobnik J, Susło R. The role of primary care physicians in enabling validation of a patient’s ability to make legal statements and express a last will. Fam Med Prim Care Rev 2017; 19: 319–322, doi: 10.5114/fmpcr.2017.69298.
16.
Bungaran Partahi Saud Manalu S, Leonard E, Paramita C, et al. Factors affecting the disease severity of COVID-19 patients in an emergency setting. Fam Med Prim Care Rev 2022; 24(1): 56–60, doi: 10.5114/fmpcr.2022.113014.
17.
Susło R, Pobrotyn P, Mierzecki A, et al. Fear of Illness and Convenient Access to Vaccines Appear to Be the Missing Keys to Successful Vaccination Campaigns: Analysis of the Factors Influencing the Decisions of Hospital Staff in Poland concerning Vaccination against Influenza and COVID-19. Vaccines 2022; 10(7): 1026, doi: 10.3390/vaccines10071026.
18.
Paplicki M, Susło R, Najjar N, et al. Conflict of individual freedom and community health safety: legal conditions on mandatory vaccinations and changes in the judicial approach in the case of avoidance. Fam Med Prim Care Rev 2018; 204: 389–395, doi: 10.5114/fmpcr.2018.80081.
19.
Paplicki M, Susło R, Benedikt A, et al. Effectively enforcing mandatory vaccination in Poland and worldwide. Fam Med Prim Care Rev 2020; 22(3): 252–256, doi: 10.5114/fmpcr.2020.98255.
20.
Susło R, Pobrotyn P, Brydak L, et al. Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study. Int J Environ Res Public Health 2021; 18(10): 5173, doi: 10.3390/ijerph18105173.
21.
Drobnik J, Susło R, Pobrotyn P, et al. COVID-19 among Healthcare Workers in the University Clinical Hospital in Wroclaw, Poland. Int J Environ Res Public Health 2021; 18(11): 5600, doi: 10.3390/ijerph18115600.
22.
EASL-EAS-EASO Clinical Practice Guidelines: For the management of Non-Alcoholic Fatty Liver Disease. J Hep 2016; doi: 10.2016/j.jhep. 2015.11.004.
23.
Belovičová M. Selected liver diseases and their impact on public health. Bardejov: SSPO; 2018.
24.
Blachier M, Leleu H, Peck-Radosavljevic M, et al. The Burden of liver disease in Europe 2013. A review of available epidemiological data. J Hepatol 2013; 58: 593–608.
25.
Belovičová M. Non-alcoholic fatty liver disease and its impact on public health. Kraków: Towarzystwo Slowakow w Polsce; 2019.
26.
Urbánek P, Husa P, Šperl J, et al. Standard diagnostic and therapeutic procedure for chronic hepatitis C virus infection. Gastroent Hepatol 2017; 71(2): 117–136.
27.
Ledesma F, Buti M, Dominiguey-Hernandez R, et al. Is the universal population Hepatitis C virus screening a cost effective strategy? A systematic review or the economic evidence. Revista Espanola de Quimioterapia 2020; 33(4): 240–248, doi: 10.37201/req/030.2020.
28.
Belovičová M, Popovičová M, Babečka J. Metabolic syndrome in seniors in care homes. Bardejov: SSPO; 2022.
29.
Kunešová M. Basics of obesitology. Praha: Galén; 2016.
30.
Ledinghen V, De, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012; 32(6): 911–918.
31.
Karlas T, Petroff D, Garnov N, et al. Non-invasive asessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS ONE 2014; 9(3): e91987, doi: 10.1371/journal.pone.0091987.
32.
Niederau C. NAFLD and NASH. In: Mauss S, Berg T, Rochstroh J, et al. Hepatology. A Clinical Textbook. 6th ed. Flying Publisher; 2015: 507–529.
33.
Brúha R. [Approach to patients with liver disease]. Vnitr Lek 2015; 61(Suppl. 4): 6–12 (in Czech).
34.
Noureddin M, Vipani A, Brese C, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol 2018; 113: 1649–1659.
35.
Jagielska A, Jankowski K, Okręglicka K, et al. Lifestyle risk factors of non-communicable diseases among patients after liver transplantation – a pilot study. Fam Med Prim Care Rev 2017; 19(3): 214–220, doi: 10.5114/fmpcr.2017.69277.
36.
Drobnik J, Trnka J, Susło R. Ambushes related to collecting patients’ consent for medical procedures by family doctors. Fam Med Prim Care Rev 2017; 19: 298–302, doi: 10.5114/fmpcr.2017.69294.
37.
Susło R, Trnka J, Drobnik J, et al. Influence of service, scientific and teaching activities of medical institutions on their information systems. Fam Med Prim Care Rev 2008; 10: 696–698.
38.
Susło R, Trnka J, Drobnik J, et al. The way of medical documents filling in as cause of faulty medical opinions. Fam Med Prim Care Rev 2009; 11: 506–508.
39.
Susło R, Trnka J, Drobnik J. Current threats to medical data security in family doctors’ practices. Fam Med Prim Care Rev 2017; 19(3): 313–318, doi: 10.5114/fmpcr.2017.69297.
40.
Trnka J, Drobnik J, Susło R. The specificity of the doctor-patient relationship in the case of the family doctor. Fam Med Prim Care Rev 2010; 12: 488–490.
41.
WHO. Guidelines on hepatitis B and C testing. February 2017 [cited 15.06.2023]. Available from URL: https://www.who.int/publications/i/item/9789241549981.
42.
WHO. Hepatitis C 2022 [cited 12.06.2023]. Available from URL: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
43.
Public health authority of the Slovak republic. Immunological review in the Slovak republic in 2018 (seroprevalence study). Final report [cited 12.06.2023]. Available from URL: https://old.uvzsr.sk/docs/info/ip/IP2018_Zaverecna_sprava.pdf.
44.
Susło R, Paplicki M, Dopierała K, et al. Fostering digital literacy in the elderly as a means to secure their health needs and human rights in the reality of the twenty-first century. Fam Med Prim Care Rev 2018; 20(3): 271–275, doi: 10.5114/fmpcr.2018.78273.
45.
Paplicki M, Susło R, Dopierała K, et al. Systemic aspects of securing the health safety of the elderly. Fam Med Prim Care Rev 2018; 20(3): 267–270, doi: 10.5114/fmpcr.2018.78272.
46.
Hartleb M, Mastalerz-Migas A, Kowalski P, et al. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. Eur J Gastroenterol Hepatol 2022; 34(4): 426–434.